TXT’s Concert In 4DX Brings MOAs To The Edge Of Their Seats—Quite Literally

Experience music like never before in “Tomorrow X Together: Hyperfocus,” the immersive 4DX concert film featuring admired hits, available at Ayala Malls Cinemas from January 15-21.

‘iNDIEGENIUS’ Project Champions Cultural Films For The Second Time Around

With its second edition, the iNDIEGENIUS Project Lab at iACADEMY provides promising filmmakers with essential tools and support to explore Indigenous storytelling.

Weaving the Past into the Future: Cebu Pacific Promotes Philippine Textile Arts

Cebu Pacific takes a step towards preserving Philippine cultural heritage through its new initiative promoting local textile arts.

5 Financial Resolutions To Keep In The New Year

The new year brings the opportunity to reassess financial priorities and set clear goals for the months ahead.

Usec. Vergeire: DOH Hopes To Start Avigan Trial By July

Avigan is an antiviral medicine that might be a possible treatment for patients infected with the COVID-19.

Usec. Vergeire: DOH Hopes To Start Avigan Trial By July

30
30

How do you feel about this story?

Like
Love
Haha
Wow
Sad
Angry

The Department of Health (DOH) is hoping to start with the clinical trial on Avigan, an antiviral medicine, by the second or third week of July.

In a virtual media forum, DOH Undersecretary Maria Rosario Vergeire said the Avigan trial is another clinical trial on the possible treatment of patients infected with the coronavirus disease 2019 (Covid-19).

“We’re just waiting for the (Congress) ethics committee clearance for this Avigan trial protocol and then, we’ll go through the regulatory clearance of the FDA (Food and Drug Administration), and, hopefully, pagdating ng July sana mga second or third week of July makakapag-umpisa na tayo ng (when the second or third week of July comes we can start with the) Avigan trial,” Vergeire added.

On May 6, Vergeire said the Japanese government would be providing enough supply of Avigan for some 100 patients who will be chosen for the trial.

As for the World Health Organization (WHO) Solidarity Trial on medicines for possible Covid-19 treatment, Vergeire said the DOH has stopped the use of hydroxychloroquine per WHO’s directive.

“Mayroong na lang pong tatlong gamot na natitira na ginagamit (We’re only using three drugs) and we have 330 patients currently enrolled among our 21 of the 26 participating hospitals that we have,” she added.
The three other drugs used in the trial are Remdesivir, Lopinavir, or Ritonavir, and Lopinavir or Ritonavir with Interferon beta-1a. (PNA)